Can the new drug Ozempic solve India’s growing metabolic health emergency?- The Week
Novo Nordisk's launch of the semaglutide drug Ozempic in India on Friday marks a turning point for a nation facing an unprecedented metabolic health emergency. But even as this GLP-1 drug enters the Indian market, critical questions remain,…